He called you dude! Gyoung with his usual childish analysis. This is going to rip your face off gyoung. Except you have no position. Except when you lost money being long a stock you hate. Now that's a moron.
Actually gdouche No One Cares what a moronic sleazy lying message board troll like yourself has to say. Get a grip stupid. This stock is going to explode UP at some short time in the future.
DUDE....stale report from Oct 6, 2014 !!! Stock broke to the DOWNSIDE under 2.00. Then with that FDA letter it dumped to 1.08-1.13 level . Way way stale news !
No one cares what you say. Post every day and hour. The stock is a dog...after 15 years ...no drug on the market... weak HD drug is the one item holding up Prana. Yet in all the 15 years millions have been paid to the management......
With ridiculous statements and attacks . With no knowledge of the science. They are actually quite laughable. From the absolutely stupid statements of lady roach chatterly to the totally moronic conclusions of gdouche.
Mar 7, 2014 10.60 10.61 9.88 10.21 1,194,400 10.21
Mar 6, 2014 11.23 11.29 10.25 10.41 1,487,800 10.41
Mar 5, 2014 11.12 11.30 10.82 10.97 658,800 10.97
Mar 4, 2014 11.05 11.50 11.00 11.02 1,131,800 11.02
Mar 3, 2014 10.61 11.09 10.49 10.82 1,944,300 10.82
Feb 28, 2014 11.62 12.22 10.50 11.31 2,519,400 11.31
Yes...just before the FAILED AD results......of 3.31.14
Yes...this time last year when this was over 10.00 ...yep smoke and mirrors manipulated, churned BS. Oh the old days ! snif
lol....ITM you will never ignore lord chatterly as you are a control freak and NEED to see very post here. LOL. Pran is still flatlined off the FDA letter and trading at levels not see in YEARS. NOT a good sign. spin spin spin...
The 50% U.S. orphan-drug tax credit is a good thing, but because Prana doesn't pay taxes in the USA and doesn't have any earnings on which to pay taxes anyway, this won't help Prana's cash flow situation anytime soon unless something like the following scenario takes place: suppose that a Big Pharma company that is either based in the USA or has a significant tax-paying presence in the USA partners with Prana and pays for an orphan-drug Phase III of PBT2 for Huntington's disease conducted in the USA. That Big Pharma company could then benefit from the 50% tax credit in real time. The benefit to Prana is that Prana wouldn't have to pay for the Phase III. It would be a win-win, in the sense that Big Pharma gets a big tax credit, along with a piece of the action in the event that PBT2 gets approved for Huntington's, while Prana would be able to deploy its cash for other projects while still retaining a piece of the action in the event that PBT2 gets approved for Huntington's.
That was not the point I was making. Who would say having over 90% wiped off your market is pretty. Considering Prana has cash and several candidates, AND NO DEBT it does smell like an opportunity.
Candidates for AD, PD, HD, Brain Cancer, and several orphan movement disorders.
They are ready to start a pivotal phase3 in a near blockbuster indication, and the enterprise value is $16m. This is a joke.
Sentiment: Strong Buy